Download Files:
Products Details
Product Description
– Lamivudine (BCH-189) salicylate is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Lamivudine salicylate can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the CNS[1][2].
Web ID
– HY-B0250A
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C15H17N3O6S
References
– [1]Li, Y.C., [A clinical study on lamivudine treatment for advanced schistosomisis with chronic B hepatits]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, 2013. 25(5): p. 548-9, 551.|[2]Zhang, C.E., et al., [Effects of lamivudine on growth of intestinal characteristic bacteria by microcalorimetry in vitro]. Yao Xue Xue Bao, 2013. 48(10): p. 1590-4.
CAS Number
– 173522-96-8
Molecular Weight
– 367.38
SMILES
– OC[C@H]1SC[C@@H](N2C(N=C(N)C=C2)=O)O1.OC3=C(C(O)=O)C=CC=C3
Clinical Information
– Launched
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HBV;HIV;Reverse Transcriptase
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
